AbbVie Inc (ABBV)

Exchange
NYSE
Symbol
ABBV
Sector
Life Sciences
Industry
Pharmaceutical Preparations
Description
AbbVie is an American publicly traded biopharmaceutical company founded in 2013. It originated as a spin-off of Abbott Laboratories.
Country
USA

Stock price

At close: November 5, 2024

  • Open
    200.49
  • High
    202.42
  • Low
    198.35
  • Close
    201.68
  • Volume
    5,109,350

Financial ratios

Dec 31, 2023

Activity ratios
Inventory turnover
8.99
Receivables turnover
4.87
Payables turnover
9.99
Working capital turnover
—
Days of inventory on hand (DOH)
40.60
Days of sales outstanding (DSO)
74.96
Number of days of payables
36.53
Fixed asset turnover
10.89
Total asset turnover
0.40
 Liquidity ratios
Current ratio
0.87
Quick ratio
0.63
Cash ratio
0.34
Cash conversion cycle
79.03
 Solvency ratios
Debt-to-assets ratio
0.00
Debt-to-capital ratio
0.00
Debt-to-equity ratio
0.00
Financial leverage ratio
13.00
Interest coverage
3.81
 Profitability ratios
Gross profit margin
32.16%
Operating profit margin
23.49%
Pretax margin
11.49%
Net profit margin
8.95%
Operating return on assets (Operating ROA)
9.47%
Return on assets (ROA)
3.61%
Return on total capital
81.70%
Return on equity (ROE)
46.94%